TWD 28.55
(-9.94%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 266.15 Million TWD | 9.99% |
2022 | 241.99 Million TWD | 44.59% |
2021 | 167.36 Million TWD | 24.58% |
2020 | 134.34 Million TWD | -19.7% |
2019 | 167.29 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 47.86 Million TWD | -35.41% |
2024 Q2 | 72.28 Million TWD | 51.01% |
2023 Q4 | 74.11 Million TWD | 10.53% |
2023 FY | 266.15 Million TWD | 9.99% |
2023 Q3 | 67.05 Million TWD | 14.05% |
2023 Q2 | 58.79 Million TWD | -11.19% |
2023 Q1 | 66.2 Million TWD | -3.73% |
2022 FY | 241.99 Million TWD | 44.59% |
2022 Q4 | 68.76 Million TWD | 0.0% |
2021 FY | 167.36 Million TWD | 24.58% |
2020 FY | 134.34 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -80799.392% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -108.474% |
Level Biotechnology Inc. | 151.99 Million TWD | -75.113% |
Sagittarius Life Science Corp | 135.85 Million TWD | -95.917% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | -250.86% |
TaiMed Biologics Inc. | 225.23 Million TWD | -18.171% |
GlycoNex Incorporation | 995 Thousand TWD | -26649.648% |
VBI | 32.55 Million TWD | -717.567% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | -3.617% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -37.064% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -478.317% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -121.966% |
Visgeneer Inc. | 67.48 Million TWD | -294.415% |
Mycenax Biotech Inc. | -375.19 Million TWD | 170.94% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 47.822% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -316.505% |
Neith Corporation | 66.87 Million TWD | -298.007% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 81.569% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -806.783% |
Enimmune corporation | 220.1 Million TWD | -20.925% |
TaiRx, Inc. | 217.13 Million TWD | -22.578% |
CHO Pharma, Inc. | 268.99 Million TWD | 1.055% |
EirGenix Inc. | 236.74 Million TWD | -12.426% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -155.061% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 25.575% |
Lin BioScience, Inc. | 1.09 Billion TWD | 75.734% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -438.01% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -24476.085% |
Lukas Biomedical Inc. | 177.45 Million TWD | -49.991% |
RBC Bioscience Corporation | 58.35 Million TWD | -356.095% |
BiOptic Inc. | 108.69 Million TWD | -144.875% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -295632.222% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -283.791% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -10078.164% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 58.666% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -185.162% |
NaviFUS Corp. | 11.82 Million TWD | -2150.435% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -39.548% |
Sinew Pharma Inc. | 186.25 Million TWD | -42.902% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -259.563% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -20.763% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -541.641% |
AP Biosciences Inc | 32.25 Million TWD | -725.222% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 85.616% |
3D Global Biotech Inc. | 5.27 Million TWD | -4946.625% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 16.124% |
Intech Biopharm Corporation | -163.99 Million TWD | 262.297% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 76.429% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -541.625% |
TWi Biotechnology, Inc. | 169.55 Million TWD | -56.974% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -81.033% |
TCI GENE Inc. | 174.61 Million TWD | -52.424% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -1478561.111% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 11.557% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 8.523% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -217.064% |
PharmaEngine, Inc. | 441.78 Million TWD | 39.754% |
Savior Lifetec Corporation | 223.36 Million TWD | -19.157% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | -2.852% |
OBI Pharma, Inc. | 2.01 Billion TWD | 86.8% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | -91.661% |
Acepodia, Inc. | 452.56 Million TWD | 41.189% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 50.797% |